Dr. Anthony Richard Deboni, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5898 Bridge St, East Syracuse, NY 13057 Phone: 315-663-0112 Fax: 315-663-0132 |
Dr. Jon B Loftus, MD Plastic Surgery - Surgery of the Hand Medicare: Accepting Medicare Assignments Practice Location: 6620 Fly Road, Ste 200, East Syracuse, NY 13057 Phone: 315-464-4472 |
Dr. Gregory Alan Baum, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5898 Bridge St, East Syracuse, NY 13057 Phone: 315-663-0112 Fax: 315-663-0132 |
Dr. Guillermo Quetell, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5000 Brittonfield Pkwy Ste A125, East Syracuse, NY 13057 Phone: 315-802-2601 Fax: 315-802-6933 |
News Archive
Sophisticated lung imaging can show whether or not a treatment drug is able to clear tuberculosis (TB) lung infection in human and macaque studies, according to researchers at the University of Pittsburgh School of Medicine and their international collaborators.
Every year, as influenza season - and flu shot season-rolls around, medical experts weigh in on just how effective it will be against that year's particular strain. What if that equation could take into account a person's own immune response?
Regular consumption of deep-fried foods such as French fries, fried chicken and doughnuts is associated with an increased risk of prostate cancer, and the effect appears to be slightly stronger with regard to more aggressive forms of the disease, according to a study by investigators at Fred Hutchinson Cancer Research Center.
A new survey from the Stanford University School of Medicine suggests that a significant number of Asian Americans living in California adopt unhealthy sun-exposure behaviors as they become more westernized.
Repros Therapeutics today announced that the Company has entered into an amendment with the National Institutes of Health (NIH) to its existing exclusive license for Proellex® that revises the existing milestones and dates for performance to provide additional time to lift the current clinical hold on Proellex or select a second generation molecule for further development from the family of anti-progestational agents covered by the license.
› Verified 5 days ago